Form 4 for BNR Burning Rock Biotech Ltd
Accepted 2026-04-02 07:17:47 ET · period of report 2026-03-31 · accession 0001193125-26-138961 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 07:17 | 2026-03-31 | BNR | Han Yusheng | Dir | P - Purchase | $17.36 | +314.9K | 17.67M | +2% | +$5.47M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares (represented by American depositary shares) | 2026-03-31 | P | A | 314,870 | $17.36 | 17,672,676 | D | — | — | (F1) One American depositary share represents ten Class A ordinary shares. (F2) The price reported is the weighted average price of American depositary shares. These American depositary shares were purchased in multiple transactions at prices ranging from $16.10 to $18.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |